Article thumbnail

The Future of HIV Prevention: Prospects for an Effective Anti-HIV Microbicide

By Jeremy Nuttall, Joseph Romano, Karen Douville, Caroline Galbreath Bsmta, William Heyward, Mark Mitchnick and Saul Walker Ba Mae


As the devastation of the HIV-AIDS epidemic continues, women are in-creasingly bearing the greatest impact, particularly in developing countries [1]. In many of these countries, nearly 60 % of people living with HIV-AIDS are women [2], and in several African countries, women 15 to 24 years of age are more than three times more likely to be infected than men the same age [3]. In South Africa, one in four women is infected by 22 years of age [4]. Globally, more than 17.5 million women are now living with HIV-AIDS [5], and there are an estimated 13.2 million infected women in sub-Saharan Africa [6]. Although effective prevention technologies and strategies do already exist, these are clearly insufficient to address the problems of the epidemic, Infect Dis Clin N Am 21 (2007) 219–239especially in developing countries. The ‘‘ABC’ ’ approach (Abstinence, Be faithful, and use Condoms) has been used with some success in a number of African countries [5,7]. However, in a survey among young women in * Corresponding author

Year: 2014
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.